Nexus - 1201 - New Times Magazine-pages

Page Content (OCR)

THE TRUTH BEHIND THE VACCINES COVER-UP THE TRUTH BEHIND THE COVER-UP VACCINES US government agencies know that vaccines containing mercury and aluminium have severe neurological effects, yet they've failed to force the manufacturers to remove these toxic metals from most vaccines including those injected into babies. Part 1 of 2 was asked to write a paper on some of the newer mechanisms of vaccine damage to the nervous system, but in the interim I came across an incredible document that should blow the lid off the cover-up being engineered by the pharmaceutical companies in conjunction with powerful governmental agencies. It all started when a friend of mine sent me a copy of a letter from Congressman David Weldon, MD, to the Director of the Centers for Disease Control (CDC), Dr Julie L. Gerberding, in which he alludes to a study by a Dr Thomas Verstraeten, then representing the CDC, on the connection between infant exposure to thimerosal-containing vaccines and neurodevelopmental injury. In this shocking letter, Congressman Weldon refers to Dr Verstraeten's study which looked at the data from the Vaccine Safety Datalink and found a significant correlation between thimerosal [an ethylmercury sodium salt] exposure via vaccines and several neurodevelopmental disorders including tics, speech and language delays and possibly ADD. Congressman Weldon questions the CDC director as to why, following this meeting, Dr Verstraeten published his results almost four years later in the journal Pediatrics to show just the opposite; that is, that there was no correlation with any neurodevelopmental prob- lems related to thimerosal exposure in infants. In this letter, Congressman Weldon refers to a report of the minutes of this meeting held in Georgia, which exposes some incredible statements by the "experts" making up this study group. The group's purpose was to eval- uate and discuss Dr Verstraeten's results and data and make recommendations that would eventually lead to possible alterations in the existing vaccine policy. I contacted Congressman Weldon's legislative assistant and he kindly sent me a com- plete copy of this report. Now, as usual in these cases, the government did not give up this report willingly; it required a Freedom of Information Act lawsuit to pry it loose. Having read the report twice and carefully analysed it, I can see why they did not want any outsiders to see it. It is a bombshell, as you shall see. In this analysis, I will not only describe and discuss this report, but also will frequently quote the participants’ words directly and supply the exact page number so others can see for themselves. The official title of the meeting was the "Scientific Review of Vaccine Safety Datalink Information". This conference, held on June 7-8, 2000, at Simpsonwood Retreat Center, Norcross, Georgia, assembled 51 scientists and physicians, of which five represented vac- cine manufacturers. These included Smith Kline Beecham, Merck, Wyeth, North American Vaccine and Aventis Pasteur. During this conference, these scientists focused on the study of the Datalink material, whose main author was Dr Thomas Verstraesten who identified himself as working at the National Immunization Program of the CDC. It was discovered by Congressman Weldon that Dr Verstraeten left the CDC shortly after this conference to work in Belgium for GlaxoSmithKline, which manufacturers vaccines—a recurring pattern that has been given the name "revolving door". It is also interesting to note that GlaxoSmithKline was involved in several lawsuits over complications secondary to their vaccines. To start off the meeting, Dr Roger Bernier, Associate Director for Science in the National Immunization Program (CDC), relates some pertinent history. He states that Congressional action in 1977 required that the Food and Drug Administration (FDA) review mercury being used in drugs and biologics (vaccines). In meeting this order, the FDA called for information from the manufacturers of vaccines and drugs. He notes that a group of European regulators and manufacturers met in April 1999 and noted the situa- tion but made no recommendations of changes. In other words, it was all for show. by Russell Blaylock, MD © 2004 Website: http://www.russellblaylockmd.com NEXUS + 17 DECEMBER 2004 — JANUARY 2005 www.nexusmagazine.com